Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided scalp nerve block in hypertensive intracerebral hemorrhage craniotomy
ChiCTR2500106043Phase 4Recruiting
- Sponsor
- Longyan First Hospital
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine and dexmedetomidine in intracerebral hemorrhage (ICH) (3 arms), sponsored by Longyan First Hospital. Primary endpoints: Hemodynamic parameters (MAP and HR) and Postoperative agitation (RASS). Started Jul 2025; status: recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on ChiCTR2500106043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106043.